Cargando…

cGMP signals in smooth muscle cells and cardiac myocytes

Detalles Bibliográficos
Autores principales:	Krawutschke, Christian, Koesling, Doris, Russwurm, Michael
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2011
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3363235/ http://dx.doi.org/10.1186/1471-2210-11-S1-P40

Ejemplares similares

Mind the gap (junction): cGMP induced by nitric oxide in cardiac myocytes originates from cardiac fibroblasts
por: Menges, Lukas, et al.
Publicado: (2019)

NO-dependent cGMP signalling in neurons and astrocytes
por: Giesen, Jan, et al.
Publicado: (2015)

PDE2, a component of the NO/cGMP signalling in the hippocampus
por: Schönle, Isabel, et al.
Publicado: (2011)

Analysis of cGMP signalling with transgenic mice expressing FRET-based cGMP sensors
por: Wen, Lai, et al.
Publicado: (2013)

The ANP/cGMP/cGMP-dependent protein kinase pathway counteracts Angiotensin II-stimulated calcium mobilization in cardiac myocytes
por: Klaiber, Michael, et al.
Publicado: (2009)

It takes two to tango: cardiac fibroblast-derived NO-induced cGMP enters cardiac myocytes and increases cAMP by inhibiting PDE3
por: Menges, Lukas, et al.
Publicado: (2023)

The role of VASP in cGMP-mediated vascular smooth muscle relaxation
por: Hildebrand, Staffan, et al.
Publicado: (2013)

Structural and mechanistic insights into cGMP signaling
por: Rauch, Annika, et al.
Publicado: (2009)

Negative feedback regulation within NO/cGMP pathway attenuates vasodilatory response in renovascular hypertension
por: Mergia, Evanthia, et al.
Publicado: (2009)

NO/cGMP signalling in platelets
por: Schinner, Elisabeth, et al.
Publicado: (2009)

Evidence for functional coupling of cGMP/cGKI signalling and TRPC channels in endothelium but not in vascular smooth muscle
por: Loga, Florian, et al.
Publicado: (2013)

Regulation of smooth muscle-specific gene expression by cGMP-dependent protein kinase
por: Zhang, Tong, et al.
Publicado: (2009)

NO-cGMP signalling and cancer therapy
por: Bian, Ka, et al.
Publicado: (2013)

cGMP-dependent signaling pathways in spinal pain processing
por: Schmidtko, Achim, et al.
Publicado: (2009)

Direct activation of PDE5 by cGMP: long-term effects within NO/cGMP signaling
por: Mullershausen, Florian, et al.
Publicado: (2003)

Transformer (Tra2β): master regulator of myosin phosphatase alternative splicing and smooth muscle responses to NO/cGMP signaling
por: Fisher, Steven A, et al.
Publicado: (2011)

Role of NO/cGMP signalling in VEGF-mediated angiogenesis
por: Jäger, Ronald, et al.
Publicado: (2011)

cGMP and PKGI are required for vascular BMP signaling
por: Schwappacher, Raphaela, et al.
Publicado: (2011)

In striatum phosphodiesterase 10A is part of a synaptic signalling complex
por: Russwurm, Corina, et al.
Publicado: (2013)

Identification of novel target proteins of cGMP/cAMP signaling pathway using cGMP/cAMP capture compound mass spectrometry (CCMS)
por: Luo, Yan, et al.
Publicado: (2009)

Cell type-specific knock out models to unravel NO/cGMP signaling in smooth muscle
por: Bettaga, Noomen, et al.
Publicado: (2013)

cGMP Signaling and Vascular Smooth Muscle Cell Plasticity
por: Lehners, Moritz, et al.
Publicado: (2018)

The role of cGMP-cGKI-signaling for duodenal bicarbonate secretion
por: Spiessberger, Beate, et al.
Publicado: (2011)

The role of cGMP-cGKI-signaling for duodenal bicarbonate secretion
por: Spiessberger, Beate, et al.
Publicado: (2009)

Correlation of vascular smooth muscle cell phenotype and cGMP signalling
por: Lehners, Moritz, et al.
Publicado: (2015)

cGMP signaling pathway is involved in Leyding cell stress response
por: Andric, Silvana, et al.
Publicado: (2007)

Signaling via guanylyl cyclase C: cGMP, Src and p21
por: Basu, Nirmalya, et al.
Publicado: (2011)

Cardiac cGMP/cGMP-dependent protein kinase I signalling requires cysteine-rich LIM-only protein 4 (CRP4) to oppose angiotensin II induced hypertrophy and fibrosis
por: Straubinger, Julia, et al.
Publicado: (2013)

Rapid nitric oxide–induced desensitization of the cGMP response is caused by increased activity of phosphodiesterase type 5 paralleled by phosphorylation of the enzyme
por: Mullershausen, Florian, et al.
Publicado: (2001)

cGMP kinase I regulates glucagon release
por: Leiss, Veronika, et al.
Publicado: (2009)

Metabolic fate of orally administered cGMP in rats
por: Liong, Elaine, et al.
Publicado: (2013)

cGMP Imaging in Brain Slices Reveals Brain Region-Specific Activity of NO-Sensitive Guanylyl Cyclases (NO-GCs) and NO-GC Stimulators
por: Peters, Stefanie, et al.
Publicado: (2018)

Subcellular distribution of cGMP signalling proteins in VSMCs of IRAG KO mice
por: Hieke, Bernhard, et al.
Publicado: (2009)

cGMP-mediated antioxidant signaling: a role for the c-Abl tyrosine kinase
por: Stephens, Robert S, et al.
Publicado: (2011)

The 10th International Conference on cGMP 2022: recent trends in cGMP research and development—meeting report
por: Friebe, Andreas, et al.
Publicado: (2023)

Cardiac natriuretic peptides inhibit TRPC6-mediated prohypertrophic signaling through cGMP-PKG pathway
por: Kinoshita, Hideyuki, et al.
Publicado: (2009)

Activation of PDE10 and PDE11
por: Jäger, Ronald, et al.
Publicado: (2011)

Comparative analysis of PDE10A isoforms
por: Russwurm, Corina, et al.
Publicado: (2011)

GAF domain-induced activation of phosphodiesterases 2 and 5
por: Jäger, Ronald, et al.
Publicado: (2009)

The neuronal PDE2A3 splice variant is targeted to membranes via dual acylation
por: Russwurm, Corina, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_74aet3drb36e167r083pu66tk3